SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'APR'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CET_A_CLQA1001_0 (PROTEIN (L-LACTATEDEHYDROGENASE)) |
2hjr | MALATE DEHYDROGENASE (Cryptosporidiumparvum) | 6 / 9 | GLY A 21ASP A 45ILE A 46TYR A 77ALA A 90ILE A 110 | APR A3001 (-3.6A)APR A3001 (-3.1A)APR A3001 (-3.8A)NoneAPR A3001 (-3.6A)APR A3001 (-3.9A) | 1.02A | 1cetA-2hjrA:44.6 | 1cetA-2hjrA:41.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1CQE_A_FLPA1650_1 (PROTEIN(PROSTAGLANDIN H2SYNTHASE-1)) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.85A | 1cqeA-5dusA:undetectable | 1cqeA-5dusA:14.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1CQE_B_FLPB2650_1 (PROTEIN(PROSTAGLANDIN H2SYNTHASE-1)) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.85A | 1cqeB-5dusA:undetectable | 1cqeB-5dusA:14.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_E_ACTE3005_0 (BETA-CARBONICANHYDRASE) |
3ewr | NON-STRUCTURALPROTEIN 3 (Humancoronavirus229E) | 4 / 7 | ASP A 51GLY A 43GLY A 44GLN A 59 | NoneAPR A 169 ( 4.5A)APR A 169 (-3.2A)None | 0.99A | 1ekjE-3ewrA:undetectable1ekjF-3ewrA:undetectable | 1ekjE-3ewrA:20.961ekjF-3ewrA:20.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EQH_A_FLPA701_1 (PROSTAGLANDIN H2SYNTHASE-1) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.86A | 1eqhA-5dusA:undetectable | 1eqhA-5dusA:14.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EQH_B_FLPB1701_1 (PROSTAGLANDIN H2SYNTHASE-1) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.87A | 1eqhB-5dusA:undetectable | 1eqhB-5dusA:14.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KQW_A_RTLA135_0 (CELLULARRETINOL-BINDINGPROTEIN) |
3gz8 | MUTT/NUDIX FAMILYPROTEIN (Shewanellaoneidensis) | 5 / 12 | PHE A 27THR A 103VAL A 90LEU A 52ILE A 146 | NoneAPR A 302 ( 4.2A)NoneNoneNone | 1.28A | 1kqwA-3gz8A:undetectable | 1kqwA-3gz8A:22.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RJD_A_SAMA801_0 (CARBOXY METHYLTRANSFERASE FORPROTEIN PHOSPHATASE2A CATALYTIC SUBUNIT) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | THR A 103ASP A 102GLY A 96GLY A 98LEU A 42 | NoneAPR A 389 ( 4.5A)NoneAPR A 389 (-3.2A)APR A 389 (-4.9A) | 1.05A | 1rjdA-1rrmA:2.5 | 1rjdA-1rrmA:20.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RJD_B_SAMB802_0 (CARBOXY METHYLTRANSFERASE FORPROTEIN PHOSPHATASE2A CATALYTIC SUBUNIT) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | THR A 103ASP A 102GLY A 96GLY A 98LEU A 42 | NoneAPR A 389 ( 4.5A)NoneAPR A 389 (-3.2A)APR A 389 (-4.9A) | 1.05A | 1rjdB-1rrmA:2.1 | 1rjdB-1rrmA:20.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RJD_C_SAMC803_0 (CARBOXY METHYLTRANSFERASE FORPROTEIN PHOSPHATASE2A CATALYTIC SUBUNIT) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | THR A 103ASP A 102GLY A 96GLY A 98LEU A 42 | NoneAPR A 389 ( 4.5A)NoneAPR A 389 (-3.2A)APR A 389 (-4.9A) | 1.06A | 1rjdC-1rrmA:2.4 | 1rjdC-1rrmA:20.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V8B_A_ADNA502_1 (ADENOSYLHOMOCYSTEINASE) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | HIS A 263ASP A 196THR A 144LEU A 259GLY A 204 | ZN A 387 ( 3.3A) ZN A 387 (-2.6A)APR A 389 (-4.0A)FE2 A 388 ( 4.1A)None | 1.31A | 1v8bA-1rrmA:2.6 | 1v8bA-1rrmA:22.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V8B_B_ADNB1502_1 (ADENOSYLHOMOCYSTEINASE) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | HIS A 263ASP A 196THR A 144LEU A 259GLY A 204 | ZN A 387 ( 3.3A) ZN A 387 (-2.6A)APR A 389 (-4.0A)FE2 A 388 ( 4.1A)None | 1.30A | 1v8bB-1rrmA:2.5 | 1v8bB-1rrmA:22.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V8B_D_ADND3502_1 (ADENOSYLHOMOCYSTEINASE) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | HIS A 263ASP A 196THR A 144LEU A 259GLY A 204 | ZN A 387 ( 3.3A) ZN A 387 (-2.6A)APR A 389 (-4.0A)FE2 A 388 ( 4.1A)None | 1.31A | 1v8bD-1rrmA:3.3 | 1v8bD-1rrmA:22.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1VQ1_A_SAMA301_0 (N5-GLUTAMINEMETHYLTRANSFERASE,HEMK) |
2hjr | MALATE DEHYDROGENASE (Cryptosporidiumparvum) | 5 / 12 | ILE A 88ALA A 247ILE A 29THR A 131PHE A 141 | NoneNoneNoneAPR A3001 (-2.5A)None | 1.32A | 1vq1A-2hjrA:3.8 | 1vq1A-2hjrA:24.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XF1_A_ACTA1107_0 (C5A PEPTIDASE) |
3gz8 | MUTT/NUDIX FAMILYPROTEIN (Shewanellaoneidensis) | 4 / 5 | LEU A 38GLY A 51HIS A 142ILE A 146 | NoneNoneAPR A 302 (-4.0A)None | 0.70A | 1xf1A-3gz8A:undetectable | 1xf1A-3gz8A:11.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XF1_B_ACTB1108_0 (C5A PEPTIDASE) |
3gz8 | MUTT/NUDIX FAMILYPROTEIN (Shewanellaoneidensis) | 4 / 6 | LEU A 38GLY A 51HIS A 142ILE A 146 | NoneNoneAPR A 302 (-4.0A)None | 0.75A | 1xf1B-3gz8A:undetectable | 1xf1B-3gz8A:11.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YC2_A_NCAA506_0 (NAD-DEPENDENTDEACETYLASE 2) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 6 | ALA A 51SER A 54PHE A 62ASN A 112ASP A 114 | APR A1296 (-3.7A)NoneAPR A1296 (-3.6A)NoneNone | 0.73A | 1yc2A-3zg6A:21.7 | 1yc2A-3zg6A:30.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YC2_A_NCAA506_0 (NAD-DEPENDENTDEACETYLASE 2) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 5 / 6 | ALA A 263SER A 266ASN A 345ILE A 346ASP A 347 | APR A 602 (-3.3A)NoneNoneNoneNone | 0.26A | 1yc2A-4iaoA:23.8 | 1yc2A-4iaoA:19.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YC2_A_NCAA506_0 (NAD-DEPENDENTDEACETYLASE 2) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 5 / 6 | ALA A 263SER A 266PHE A 274ASN A 345ILE A 346 | APR A 602 (-3.3A)NoneAPR A 602 (-3.5A)NoneNone | 0.71A | 1yc2A-4iaoA:23.8 | 1yc2A-4iaoA:19.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YC2_D_NCAD510_0 (NAD-DEPENDENTDEACETYLASE 2) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 4 / 5 | ALA A 51PHE A 62ASN A 112ASP A 114 | APR A1296 (-3.7A)APR A1296 (-3.6A)NoneNone | 0.67A | 1yc2D-3zg6A:21.8 | 1yc2D-3zg6A:30.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YC2_D_NCAD510_0 (NAD-DEPENDENTDEACETYLASE 2) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 5 / 5 | ALA A 263PHE A 274ASN A 345ILE A 346ASP A 347 | APR A 602 (-3.3A)APR A 602 (-3.5A)NoneNoneNone | 0.59A | 1yc2D-4iaoA:23.7 | 1yc2D-4iaoA:19.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YC2_E_NCAE507_0 (NAD-DEPENDENTDEACETYLASE 2) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 4 / 7 | ILE A 59PHE A 62ASN A 112ASP A 114 | NoneAPR A1296 (-3.6A)NoneNone | 0.28A | 1yc2E-3zg6A:22.5 | 1yc2E-3zg6A:30.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YC2_E_NCAE507_0 (NAD-DEPENDENTDEACETYLASE 2) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 5 / 7 | ILE A 271PHE A 274ASN A 345ILE A 346ASP A 347 | NoneAPR A 602 (-3.5A)NoneNoneNone | 0.47A | 1yc2E-4iaoA:26.7 | 1yc2E-4iaoA:19.25 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YC5_A_NCAA2001_0 (NAD-DEPENDENTDEACETYLASE) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 7 | ALA A 51SER A 54ILE A 59ASN A 112ASP A 114 | APR A1296 (-3.7A)NoneNoneNoneNone | 0.36A | 1yc5A-3zg6A:23.7 | 1yc5A-3zg6A:34.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YC5_A_NCAA2001_0 (NAD-DEPENDENTDEACETYLASE) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 6 / 7 | ALA A 263SER A 266ILE A 271ASN A 345ILE A 346ASP A 347 | APR A 602 (-3.3A)NoneNoneNoneNoneNone | 0.48A | 1yc5A-4iaoA:20.9 | 1yc5A-4iaoA:21.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YC5_A_NCAA2001_0 (NAD-DEPENDENTDEACETYLASE) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 4 / 7 | SER A 266ILE A 271ASP A 273ASP A 347 | NoneNoneAPR A 602 (-3.9A)None | 0.84A | 1yc5A-4iaoA:20.9 | 1yc5A-4iaoA:21.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AYL_A_FLPA1701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.90A | 2aylA-5dusA:undetectable | 2aylA-5dusA:15.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AYL_B_FLPB2701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.89A | 2aylB-5dusA:undetectable | 2aylB-5dusA:15.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BM9_F_SAMF301_0 (CEPHALOSPORINHYDROXYLASE CMCI) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | GLY A 97GLY A 194ALA A 197HIS A 200ALA A 250 | APR A 389 (-3.1A)NoneNone ZN A 387 ( 3.3A)None | 1.02A | 2bm9F-1rrmA:undetectable | 2bm9F-1rrmA:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BM9_F_SAMF301_0 (CEPHALOSPORINHYDROXYLASE CMCI) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | GLY A 98GLY A 194ALA A 197HIS A 200ALA A 250 | APR A 389 (-3.2A)NoneNone ZN A 387 ( 3.3A)None | 0.84A | 2bm9F-1rrmA:undetectable | 2bm9F-1rrmA:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2C12_F_SPMF1433_1 (NITROALKANE OXIDASE) |
1wvg | CDP-GLUCOSE4,6-DEHYDRATASE (Salmonellaenterica) | 5 / 11 | MET A 89LEU A 27ALA A 195SER A 242LEU A 241 | APR A 400 (-4.9A)NoneNoneNoneNone | 1.31A | 2c12F-1wvgA:undetectable | 2c12F-1wvgA:21.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F16_2_BO221405_1 (PROTEASOME COMPONENTPRE3) |
1txz | HYPOTHETICAL 32.1KDA PROTEIN INADH3-RCA1 INTERGENICREGION (Saccharomycescerevisiae) | 5 / 11 | THR A 148ALA A 198GLY A 118ALA A 173SER A 81 | APR A 285 (-2.8A)APR A 285 (-3.4A)NoneNoneNone | 1.20A | 2f162-1txzA:undetectable | 2f162-1txzA:22.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F16_N_BO2N1404_1 (PROTEASOME COMPONENTPRE3) |
1txz | HYPOTHETICAL 32.1KDA PROTEIN INADH3-RCA1 INTERGENICREGION (Saccharomycescerevisiae) | 5 / 11 | THR A 148ALA A 198GLY A 118ALA A 173SER A 81 | APR A 285 (-2.8A)APR A 285 (-3.4A)NoneNoneNone | 1.20A | 2f16N-1txzA:undetectable | 2f16N-1txzA:22.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2FK8_A_SAMA302_0 (METHOXY MYCOLIC ACIDSYNTHASE 4) |
1wvg | CDP-GLUCOSE4,6-DEHYDRATASE (Salmonellaenterica) | 5 / 12 | GLY A 18GLY A 21LEU A 43GLY A 66ALA A 90 | APR A 400 (-3.2A)APR A 400 (-3.2A)APR A 400 (-4.1A)NoneAPR A 400 (-3.4A) | 0.82A | 2fk8A-1wvgA:5.1 | 2fk8A-1wvgA:23.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2H4J_A_NCAA1002_0 (NAD-DEPENDENTDEACETYLASE) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 4 / 5 | ALA A 51ILE A 59ASN A 112ASP A 114 | APR A1296 (-3.7A)NoneNoneNone | 0.33A | 2h4jA-3zg6A:23.9 | 2h4jA-3zg6A:34.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H4J_A_NCAA1002_0 (NAD-DEPENDENTDEACETYLASE) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 5 / 5 | ALA A 263ILE A 271ASN A 345ILE A 346ASP A 347 | APR A 602 (-3.3A)NoneNoneNoneNone | 0.53A | 2h4jA-4iaoA:20.7 | 2h4jA-4iaoA:21.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HJH_A_NCAA900_0 (NAD-DEPENDENTHISTONE DEACETYLASESIR2) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 5 / 5 | ILE A 271PRO A 272PHE A 274PHE A 280ILE A 346 | NoneNoneAPR A 602 (-3.5A)NoneNone | 0.32A | 2hjhA-4iaoA:44.7 | 2hjhA-4iaoA:99.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HJH_B_NCAB901_0 (NAD-DEPENDENTHISTONE DEACETYLASESIR2) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 4 / 5 | ILE A 271PRO A 272PHE A 274VAL A 315 | NoneNoneAPR A 602 (-3.5A)None | 0.43A | 2hjhB-4iaoA:44.1 | 2hjhB-4iaoA:99.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NMZ_B_ROCB401_1 (PROTEASE) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 6 / 12 | GLY A 67ASP A 39ILE A 95ILE A 107ALA A 63ILE A 64 | NoneAPR A 389 (-2.7A)NoneNoneNoneNone | 1.26A | 2nmzA-1rrmA:undetectable | 2nmzA-1rrmA:16.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NV4_B_SAMB202_0 (UPF0066 PROTEINAF_0241) |
3q6z | POLY [ADP-RIBOSE]POLYMERASE 14 (Homosapiens) | 5 / 12 | ALA A 822PRO A 883GLY A 862LEU A 860SER A 904 | APR A 1 (-3.3A)NoneNoneNoneNone | 1.36A | 2nv4B-3q6zA:undetectable | 2nv4B-3q6zA:20.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OA1_B_ADNB2005_1 (TRYPTOPHANHALOGENASE) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 4 / 7 | GLY A 471GLY A 264VAL A 500LEU A 494 | APR A 602 (-3.7A)APR A 602 (-3.3A)NoneNone | 0.79A | 2oa1B-4iaoA:2.6 | 2oa1B-4iaoA:23.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QBO_A_CAMA442_0 (CYTOCHROME P450-CAM) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 10 | TYR A 111VAL A 149VAL A 14VAL A 153VAL A 152 | NoneNoneNoneNoneAPR A 201 (-4.8A) | 1.39A | 2qboA-5dusA:undetectable | 2qboA-5dusA:16.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QMZ_A_LDPA501_1 (RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE) |
1txz | HYPOTHETICAL 32.1KDA PROTEIN INADH3-RCA1 INTERGENICREGION (Saccharomycescerevisiae) | 4 / 7 | GLY A 79PHE A 106ILE A 143PHE A 102 | APR A 285 (-3.6A)NoneNoneNone | 0.94A | 2qmzA-1txzA:undetectable2qmzB-1txzA:undetectable | 2qmzA-1txzA:21.002qmzB-1txzA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2RKF_A_AB1A501_2 (PROTEASE RETROPEPSIN) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 6 / 12 | GLY A 67ASP A 39ILE A 36ILE A 107ALA A 63ILE A 64 | NoneAPR A 389 (-2.7A)NoneNoneNoneNone | 1.44A | 2rkfB-1rrmA:undetectable | 2rkfB-1rrmA:14.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2UVN_A_ECNA1409_1 (CYTOCHROME P450 130) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | LEU A 108THR A 213GLY A 212GLY A 52LEU A 96 | NoneAPR A1296 (-3.7A)APR A1296 (-3.6A)APR A1296 (-3.3A)None | 1.02A | 2uvnA-3zg6A:undetectable | 2uvnA-3zg6A:22.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W3A_A_TOPA1190_1 (DIHYDROFOLATEREDUCTASE) |
4epp | POLY(ADP-RIBOSE)GLYCOHYDROLASE (Tetrahymenathermophila) | 5 / 11 | ILE A 324ALA A 326GLU A 344ILE A 395VAL A 236 | NoneAPR A 501 ( 4.6A)NoneNoneNone | 1.12A | 2w3aA-4eppA:undetectable | 2w3aA-4eppA:17.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2X0P_A_ADNA1607_1 (ALCALIGINBIOSYNTHESIS PROTEIN) |
1v8y | ADP-RIBOSEPYROPHOSPHATASE (Thermusthermophilus) | 4 / 8 | GLY A 67ILE A 19ALA A 78GLU A 70 | ZN A 300 ( 4.5A)APR A 619 (-4.5A)None ZN A 301 (-2.3A) | 0.93A | 2x0pA-1v8yA:undetectable | 2x0pA-1v8yA:17.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2X45_A_HSMA1161_1 (ALLERGEN ARG R 1) |
3ewr | NON-STRUCTURALPROTEIN 3 (Humancoronavirus229E) | 4 / 5 | VAL A 52TYR A 53VAL A 20ASP A 19 | NoneNoneAPR A 169 (-4.3A)None | 1.29A | 2x45A-3ewrA:undetectable | 2x45A-3ewrA:18.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2X45_C_HSMC1161_1 (ALLERGEN ARG R 1) |
3ewr | NON-STRUCTURALPROTEIN 3 (Humancoronavirus229E) | 4 / 5 | VAL A 52TYR A 53VAL A 20ASP A 19 | NoneNoneAPR A 169 (-4.3A)None | 1.33A | 2x45C-3ewrA:undetectable | 2x45C-3ewrA:18.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZW9_A_SAMA801_0 (LEUCINE CARBOXYLMETHYLTRANSFERASE 2) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 5 / 12 | ILE A 516SER A 323GLY A 471GLY A 264LEU A 494 | NoneNoneAPR A 602 (-3.7A)APR A 602 (-3.3A)None | 0.95A | 2zw9A-4iaoA:2.0 | 2zw9A-4iaoA:20.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG1_O_CHDO229_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 2CYTOCHROME C OXIDASESUBUNIT 6A2) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 11 | PHE A 14GLY A 15GLY A 240GLN A 247THR A 141 | NoneNoneNoneNoneAPR A 389 (-2.7A) | 1.16A | 3ag1G-1rrmA:0.03ag1N-1rrmA:0.13ag1O-1rrmA:0.0 | 3ag1G-1rrmA:10.573ag1N-1rrmA:22.453ag1O-1rrmA:19.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CE6_D_ADND500_1 (ADENOSYLHOMOCYSTEINASE) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | HIS A 263ASP A 196THR A 144LEU A 259GLY A 204 | ZN A 387 ( 3.3A) ZN A 387 (-2.6A)APR A 389 (-4.0A)FE2 A 388 ( 4.1A)None | 1.36A | 3ce6D-1rrmA:2.7 | 3ce6D-1rrmA:22.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3D4S_A_TIMA401_2 (BETA-2 ADRENERGICRECEPTOR/T4-LYSOZYMECHIMERA) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 3 / 3 | THR A 49SER A 110PHE A 62 | NoneNoneAPR A1296 (-3.6A) | 0.88A | 3d4sA-3zg6A:undetectable | 3d4sA-3zg6A:19.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FPJ_B_SAMB301_1 (PUTATIVEUNCHARACTERIZEDPROTEIN) |
4epp | POLY(ADP-RIBOSE)GLYCOHYDROLASE (Tetrahymenathermophila) | 4 / 7 | GLN A 335GLY A 367GLY A 373ALA A 326 | NoneAPR A 501 (-2.9A)NoneAPR A 501 ( 4.6A) | 0.79A | 3fpjB-4eppA:undetectable | 3fpjB-4eppA:19.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G1U_B_ADNB438_1 (ADENOSYLHOMOCYSTEINASE) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | HIS A 263ASP A 196THR A 144LEU A 259GLY A 204 | ZN A 387 ( 3.3A) ZN A 387 (-2.6A)APR A 389 (-4.0A)FE2 A 388 ( 4.1A)None | 1.37A | 3g1uB-1rrmA:3.6 | 3g1uB-1rrmA:25.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G1U_B_ADNB438_1 (ADENOSYLHOMOCYSTEINASE) |
2qjo | BIFUNCTIONAL NMNADENYLYLTRANSFERASE/NUDIX HYDROLASE (Synechocystissp.PCC6803) | 5 / 12 | HIS A 328GLN A 330ASP A 205THR A 203PHE A 272 | APR A 501 (-4.0A)NoneAPR A 501 (-2.8A)APR A 501 (-3.6A)None | 1.34A | 3g1uB-2qjoA:2.4 | 3g1uB-2qjoA:21.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GSS_A_EAAA212_1 (GLUTATHIONES-TRANSFERASE P1-1) |
4epp | POLY(ADP-RIBOSE)GLYCOHYDROLASE (Tetrahymenathermophila) | 4 / 7 | TYR A 293VAL A 261ILE A 227THR A 233 | NoneNoneAPR A 501 (-3.9A)None | 0.99A | 3gssA-4eppA:undetectable | 3gssA-4eppA:17.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IB1_A_IMNA701_1 (LACTOTRANSFERRIN) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 4 / 4 | PRO A 89THR A 90GLY A 212THR A 213 | NoneNoneAPR A1296 (-3.6A)APR A1296 (-3.7A) | 1.05A | 3ib1A-3zg6A:undetectable | 3ib1A-3zg6A:23.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LM8_B_VIBB223_1 (THIAMINEPYROPHOSPHOKINASE) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 4 / 7 | LEU A 474LEU A 260CYH A 469ASN A 496 | NoneNoneNoneAPR A 602 (-3.2A) | 0.87A | 3lm8B-4iaoA:3.33lm8D-4iaoA:2.9 | 3lm8B-4iaoA:18.623lm8D-4iaoA:18.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LM8_C_VIBC223_1 (THIAMINEPYROPHOSPHOKINASE) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 4 / 8 | LEU A 474LEU A 260CYH A 469ASN A 496 | NoneNoneNoneAPR A 602 (-3.2A) | 0.88A | 3lm8A-4iaoA:2.63lm8C-4iaoA:undetectable | 3lm8A-4iaoA:18.623lm8C-4iaoA:18.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LM8_D_VIBD223_1 (THIAMINEPYROPHOSPHOKINASE) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 4 / 8 | LEU A 474LEU A 260CYH A 469ASN A 496 | NoneNoneNoneAPR A 602 (-3.2A) | 0.76A | 3lm8B-4iaoA:3.03lm8D-4iaoA:2.9 | 3lm8B-4iaoA:18.623lm8D-4iaoA:18.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LN1_A_CELA682_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.93A | 3ln1A-5dusA:undetectable | 3ln1A-5dusA:15.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LN1_B_CELB682_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.91A | 3ln1B-5dusA:undetectable | 3ln1B-5dusA:15.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LN1_C_CELC682_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.92A | 3ln1C-5dusA:undetectable | 3ln1C-5dusA:15.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LN1_D_CELD682_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.93A | 3ln1D-5dusA:undetectable | 3ln1D-5dusA:15.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_A_SAMA465_0 (RRNA METHYLASE) |
3ewr | NON-STRUCTURALPROTEIN 3 (Humancoronavirus229E) | 5 / 12 | GLY A 44GLY A 43ASP A 19ASP A 51LEU A 85 | APR A 169 (-3.2A)APR A 169 ( 4.5A)NoneNoneNone | 0.96A | 3m6vA-3ewrA:undetectable | 3m6vA-3ewrA:16.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_B_SAMB465_0 (RRNA METHYLASE) |
3ewr | NON-STRUCTURALPROTEIN 3 (Humancoronavirus229E) | 5 / 12 | GLY A 44GLY A 43ASP A 19ASP A 51LEU A 85 | APR A 169 (-3.2A)APR A 169 ( 4.5A)NoneNoneNone | 0.98A | 3m6vB-3ewrA:undetectable | 3m6vB-3ewrA:16.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MG0_2_BO221405_1 (PROTEASOME COMPONENTPRE3PROTEASOME COMPONENTPUP1) |
1txz | HYPOTHETICAL 32.1KDA PROTEIN INADH3-RCA1 INTERGENICREGION (Saccharomycescerevisiae) | 5 / 12 | THR A 148ALA A 198SER A 119GLY A 118ALA A 173 | APR A 285 (-2.8A)APR A 285 (-3.4A)NoneNoneNone | 1.07A | 3mg02-1txzA:undetectable3mg0V-1txzA:undetectable | 3mg02-1txzA:22.153mg0V-1txzA:22.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N0H_A_TOPA187_1 (DIHYDROFOLATEREDUCTASE) |
4epp | POLY(ADP-RIBOSE)GLYCOHYDROLASE (Tetrahymenathermophila) | 5 / 11 | ILE A 324ALA A 326GLU A 344ILE A 395VAL A 236 | NoneAPR A 501 ( 4.6A)NoneNoneNone | 1.13A | 3n0hA-4eppA:undetectable | 3n0hA-4eppA:17.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N58_C_ADNC500_1 (ADENOSYLHOMOCYSTEINASE) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | HIS A 263ASP A 196THR A 144LEU A 259GLY A 204 | ZN A 387 ( 3.3A) ZN A 387 (-2.6A)APR A 389 (-4.0A)FE2 A 388 ( 4.1A)None | 1.36A | 3n58C-1rrmA:2.3 | 3n58C-1rrmA:22.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N8W_A_FLPA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.91A | 3n8wA-5dusA:undetectable | 3n8wA-5dusA:15.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N8Z_A_FLPA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.85A | 3n8zA-5dusA:undetectable | 3n8zA-5dusA:15.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NT1_A_NPSA5_1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.88A | 3nt1A-5dusA:undetectable | 3nt1A-5dusA:15.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NT1_B_NPSB4_1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.86A | 3nt1B-5dusA:undetectable | 3nt1B-5dusA:15.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NV6_A_CAMA422_0 (CYTOCHROME P450) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 3 / 3 | GLY A 270ILE A 154VAL A 153 | NoneNoneAPR A 389 (-4.6A) | 0.40A | 3nv6A-1rrmA:1.2 | 3nv6A-1rrmA:21.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PGH_D_FLPD701_1 (CYCLOOXYGENASE-2) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.87A | 3pghD-5dusA:undetectable | 3pghD-5dusA:15.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PP7_B_SVRB499_1 (PYRUVATE KINASE) |
1txz | HYPOTHETICAL 32.1KDA PROTEIN INADH3-RCA1 INTERGENICREGION (Saccharomycescerevisiae) | 5 / 10 | THR A 29PRO A 191ASN A 25GLY A 196GLY A 52 | NoneAPR A 285 ( 4.9A)NoneAPR A 285 (-3.2A)SO4 A 288 ( 3.4A) | 1.21A | 3pp7B-1txzA:undetectable | 3pp7B-1txzA:20.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RR3_A_FLRA700_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.92A | 3rr3A-5dusA:undetectable | 3rr3A-5dusA:15.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RR3_B_FLRB700_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.91A | 3rr3B-5dusA:undetectable | 3rr3B-5dusA:15.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3S3V_A_TOPA187_1 (DIHYDROFOLATEREDUCTASE) |
4epp | POLY(ADP-RIBOSE)GLYCOHYDROLASE (Tetrahymenathermophila) | 5 / 12 | ILE A 324ALA A 326GLU A 344ILE A 395VAL A 236 | NoneAPR A 501 ( 4.6A)NoneNoneNone | 1.11A | 3s3vA-4eppA:undetectable | 3s3vA-4eppA:17.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TVX_B_PNXB902_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4A) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 4 / 7 | ASN A 112ILE A 59PHE A 80PHE A 62 | NoneNoneNoneAPR A1296 (-3.6A) | 1.27A | 3tvxB-3zg6A:undetectable | 3tvxB-3zg6A:21.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W37_A_ACRA1001_1 (ALPHA-GLUCOSIDASE) |
3gz8 | MUTT/NUDIX FAMILYPROTEIN (Shewanellaoneidensis) | 5 / 12 | ALA A 97ASP A 23ASP A 96PHE A 140HIS A 142 | NoneAPR A 302 (-2.9A)APR A 302 (-3.6A)APR A 302 (-3.6A)APR A 302 (-4.0A) | 1.45A | 3w37A-3gz8A:undetectable | 3w37A-3gz8A:11.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WEL_A_ACRA1001_1 (ALPHA-GLUCOSIDASE) |
3gz8 | MUTT/NUDIX FAMILYPROTEIN (Shewanellaoneidensis) | 5 / 12 | ALA A 97ASP A 23ASP A 96PHE A 140HIS A 142 | NoneAPR A 302 (-2.9A)APR A 302 (-3.6A)APR A 302 (-3.6A)APR A 302 (-4.0A) | 1.46A | 3welA-3gz8A:undetectable | 3welA-3gz8A:11.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WEN_A_ACRA1001_1 (ALPHA-GLUCOSIDASE) |
3gz8 | MUTT/NUDIX FAMILYPROTEIN (Shewanellaoneidensis) | 5 / 12 | ALA A 97ASP A 23ASP A 96PHE A 140HIS A 142 | NoneAPR A 302 (-2.9A)APR A 302 (-3.6A)APR A 302 (-3.6A)APR A 302 (-4.0A) | 1.50A | 3wenA-3gz8A:undetectable | 3wenA-3gz8A:11.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WEO_A_ACRA1001_1 (ALPHA-GLUCOSIDASE) |
3gz8 | MUTT/NUDIX FAMILYPROTEIN (Shewanellaoneidensis) | 5 / 12 | ALA A 97ASP A 23ASP A 96PHE A 140HIS A 142 | NoneAPR A 302 (-2.9A)APR A 302 (-3.6A)APR A 302 (-3.6A)APR A 302 (-4.0A) | 1.45A | 3weoA-3gz8A:undetectable | 3weoA-3gz8A:11.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A97_A_ZPCA1318_2 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
3ewr | NON-STRUCTURALPROTEIN 3 (Humancoronavirus229E) | 4 / 7 | PHE A 7TYR A 16VAL A 151ILE A 121 | NoneNoneAPR A 169 ( 4.6A)None | 0.94A | 4a97E-3ewrA:undetectable | 4a97E-3ewrA:19.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A97_D_ZPCD1318_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
3ewr | NON-STRUCTURALPROTEIN 3 (Humancoronavirus229E) | 4 / 8 | PHE A 7TYR A 16VAL A 151ILE A 121 | NoneNoneAPR A 169 ( 4.6A)None | 0.94A | 4a97C-3ewrA:undetectable | 4a97C-3ewrA:19.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A97_E_ZPCE1318_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
3ewr | NON-STRUCTURALPROTEIN 3 (Humancoronavirus229E) | 4 / 8 | PHE A 7TYR A 16VAL A 151ILE A 121 | NoneNoneAPR A 169 ( 4.6A)None | 0.93A | 4a97D-3ewrA:undetectable | 4a97D-3ewrA:19.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A97_H_ZPCH1318_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
3ewr | NON-STRUCTURALPROTEIN 3 (Humancoronavirus229E) | 4 / 8 | PHE A 7TYR A 16VAL A 151ILE A 121 | NoneNoneAPR A 169 ( 4.6A)None | 0.90A | 4a97G-3ewrA:undetectable | 4a97G-3ewrA:19.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A97_I_ZPCI1318_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
3ewr | NON-STRUCTURALPROTEIN 3 (Humancoronavirus229E) | 4 / 7 | PHE A 7TYR A 16VAL A 151ILE A 121 | NoneNoneAPR A 169 ( 4.6A)None | 0.93A | 4a97H-3ewrA:undetectable | 4a97H-3ewrA:19.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A97_J_ZPCJ1318_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
3ewr | NON-STRUCTURALPROTEIN 3 (Humancoronavirus229E) | 4 / 8 | PHE A 7TYR A 16VAL A 151ILE A 121 | NoneNoneAPR A 169 ( 4.6A)None | 0.94A | 4a97I-3ewrA:undetectable | 4a97I-3ewrA:19.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BBO_C_ACTC1113_0 (BLR5658 PROTEIN) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 4 / 4 | ASN A 112ALA A 51GLY A 50THR A 213 | NoneAPR A1296 (-3.7A)APR A1296 (-3.2A)APR A1296 (-3.7A) | 1.20A | 4bboC-3zg6A:undetectable | 4bboC-3zg6A:17.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BBO_C_ACTC1113_0 (BLR5658 PROTEIN) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 4 / 4 | ASN A 345ALA A 263GLY A 262THR A 472 | NoneAPR A 602 (-3.3A)APR A 602 (-3.1A)APR A 602 (-4.0A) | 1.27A | 4bboC-4iaoA:undetectable | 4bboC-4iaoA:11.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E3A_A_ADNA500_1 (SUGAR KINASE PROTEIN) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | ILE A 53GLY A 212GLY A 52THR A 90LEU A 116 | NoneAPR A1296 (-3.6A)APR A1296 (-3.3A)NoneNone | 1.10A | 4e3aA-3zg6A:4.6 | 4e3aA-3zg6A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FGK_A_0TXA302_1 (RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE[QUINONE]) |
1txz | HYPOTHETICAL 32.1KDA PROTEIN INADH3-RCA1 INTERGENICREGION (Saccharomycescerevisiae) | 4 / 7 | GLY A 86GLY A 87TYR A 197GLU A 103 | EDO A 286 (-3.7A)APR A 285 (-3.3A)APR A 285 (-4.0A)None | 0.86A | 4fgkB-1txzA:undetectable | 4fgkB-1txzA:21.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FGL_D_CLQD303_0 (RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE[QUINONE]) |
1txz | HYPOTHETICAL 32.1KDA PROTEIN INADH3-RCA1 INTERGENICREGION (Saccharomycescerevisiae) | 4 / 7 | GLY A 79PHE A 106ILE A 143PHE A 102 | APR A 285 (-3.6A)NoneNoneNone | 0.79A | 4fglC-1txzA:undetectable | 4fglC-1txzA:21.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HYF_A_NCAA1201_0 (TANKYRASE-2) |
1wvg | CDP-GLUCOSE4,6-DEHYDRATASE (Salmonellaenterica) | 4 / 7 | HIS A 19GLY A 40ALA A 90TYR A 41 | NoneNoneAPR A 400 (-3.4A)None | 0.85A | 4hyfA-1wvgA:undetectable | 4hyfA-1wvgA:19.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HYF_B_NCAB1201_0 (TANKYRASE-2) |
1wvg | CDP-GLUCOSE4,6-DEHYDRATASE (Salmonellaenterica) | 4 / 8 | HIS A 19GLY A 40ALA A 90TYR A 41 | NoneNoneAPR A 400 (-3.4A)None | 0.88A | 4hyfB-1wvgA:undetectable | 4hyfB-1wvgA:19.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HYF_C_NCAC1201_0 (TANKYRASE-2) |
1wvg | CDP-GLUCOSE4,6-DEHYDRATASE (Salmonellaenterica) | 4 / 8 | HIS A 19GLY A 40ALA A 90TYR A 41 | NoneNoneAPR A 400 (-3.4A)None | 0.84A | 4hyfC-1wvgA:undetectable | 4hyfC-1wvgA:19.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JKU_B_ADNB500_1 (PROBABLE SUGARKINASE PROTEIN) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | ILE A 53GLY A 212GLY A 52THR A 90LEU A 116 | NoneAPR A1296 (-3.6A)APR A1296 (-3.3A)NoneNone | 1.07A | 4jkuB-3zg6A:4.6 | 4jkuB-3zg6A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K8P_A_ADNA401_1 (SUGAR KINASE) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | ILE A 53GLY A 212GLY A 52THR A 90LEU A 116 | NoneAPR A1296 (-3.6A)APR A1296 (-3.3A)NoneNone | 1.09A | 4k8pA-3zg6A:4.7 | 4k8pA-3zg6A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K8P_B_ADNB401_1 (SUGAR KINASE) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | ILE A 53GLY A 212GLY A 52THR A 90LEU A 116 | NoneAPR A1296 (-3.6A)APR A1296 (-3.3A)NoneNone | 1.09A | 4k8pB-3zg6A:4.7 | 4k8pB-3zg6A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K8T_A_ADNA401_1 (SUGAR KINASE) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | ILE A 53GLY A 212GLY A 52THR A 90LEU A 116 | NoneAPR A1296 (-3.6A)APR A1296 (-3.3A)NoneNone | 1.08A | 4k8tA-3zg6A:3.4 | 4k8tA-3zg6A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K8T_B_ADNB401_1 (SUGAR KINASE) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | ILE A 53GLY A 212GLY A 52THR A 90LEU A 116 | NoneAPR A1296 (-3.6A)APR A1296 (-3.3A)NoneNone | 1.09A | 4k8tB-3zg6A:4.8 | 4k8tB-3zg6A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K93_A_ADNA401_1 (SUGAR KINASE) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | ILE A 53GLY A 212GLY A 52THR A 90LEU A 116 | NoneAPR A1296 (-3.6A)APR A1296 (-3.3A)NoneNone | 1.09A | 4k93A-3zg6A:3.2 | 4k93A-3zg6A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K9C_A_ADNA401_1 (SUGAR KINASE) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | ILE A 53GLY A 212GLY A 52THR A 90LEU A 116 | NoneAPR A1296 (-3.6A)APR A1296 (-3.3A)NoneNone | 1.08A | 4k9cA-3zg6A:4.7 | 4k9cA-3zg6A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K9C_B_ADNB401_1 (SUGAR KINASE) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | ILE A 53GLY A 212GLY A 52THR A 90LEU A 116 | NoneAPR A1296 (-3.6A)APR A1296 (-3.3A)NoneNone | 1.09A | 4k9cB-3zg6A:3.4 | 4k9cB-3zg6A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KAD_A_ADNA401_1 (PROBABLE SUGARKINASE PROTEIN) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | ILE A 53GLY A 212GLY A 52THR A 90LEU A 116 | NoneAPR A1296 (-3.6A)APR A1296 (-3.3A)NoneNone | 1.08A | 4kadA-3zg6A:3.2 | 4kadA-3zg6A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KAD_B_ADNB401_1 (PROBABLE SUGARKINASE PROTEIN) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | ILE A 53GLY A 212GLY A 52THR A 90LEU A 116 | NoneAPR A1296 (-3.6A)APR A1296 (-3.3A)NoneNone | 1.09A | 4kadB-3zg6A:3.2 | 4kadB-3zg6A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LBX_A_ADNA401_1 (PROBABLE SUGARKINASE PROTEIN) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | ILE A 53GLY A 212GLY A 52THR A 90LEU A 116 | NoneAPR A1296 (-3.6A)APR A1296 (-3.3A)NoneNone | 1.09A | 4lbxA-3zg6A:4.9 | 4lbxA-3zg6A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LBX_B_ADNB401_1 (PROBABLE SUGARKINASE PROTEIN) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | ILE A 53GLY A 212GLY A 52THR A 90LEU A 116 | NoneAPR A1296 (-3.6A)APR A1296 (-3.3A)NoneNone | 1.10A | 4lbxB-3zg6A:4.9 | 4lbxB-3zg6A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LC4_A_ADNA401_1 (PROBABLE SUGARKINASE PROTEIN) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | ILE A 53GLY A 212GLY A 52THR A 90LEU A 116 | NoneAPR A1296 (-3.6A)APR A1296 (-3.3A)NoneNone | 1.08A | 4lc4A-3zg6A:4.6 | 4lc4A-3zg6A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LC4_B_ADNB401_1 (PROBABLE SUGARKINASE PROTEIN) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 5 / 12 | ILE A 53GLY A 212GLY A 52THR A 90LEU A 116 | NoneAPR A1296 (-3.6A)APR A1296 (-3.3A)NoneNone | 1.09A | 4lc4B-3zg6A:4.8 | 4lc4B-3zg6A:22.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NKX_C_STRC601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | ALA A 356GLY A 270ALA A 271THR A 155VAL A 153 | NoneNoneNoneNoneAPR A 389 (-4.6A) | 1.06A | 4nkxC-1rrmA:undetectable | 4nkxC-1rrmA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NKX_D_STRD601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | ALA A 356GLY A 270ALA A 271THR A 155VAL A 153 | NoneNoneNoneNoneAPR A 389 (-4.6A) | 1.03A | 4nkxD-1rrmA:undetectable | 4nkxD-1rrmA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O8Z_A_BBIA402_1 (NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-3,MITOCHONDRIAL) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 4 / 5 | PHE A 296HIS A 364LEU A 449PRO A 478 | NoneAPR A 602 (-4.1A)NoneNone | 0.88A | 4o8zA-4iaoA:26.2 | 4o8zA-4iaoA:27.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PH9_A_IBPA601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 10 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.88A | 4ph9A-5dusA:undetectable | 4ph9A-5dusA:15.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PH9_B_IBPB601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 10 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.86A | 4ph9B-5dusA:undetectable | 4ph9B-5dusA:15.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QB9_D_PARD500_1 (ENHANCEDINTRACELLULARSURVIVAL PROTEIN) |
4epp | POLY(ADP-RIBOSE)GLYCOHYDROLASE (Tetrahymenathermophila) | 4 / 8 | PHE A 238SER A 362ASP A 223ASP A 224 | APR A 501 (-4.7A)NoneNoneNone | 1.32A | 4qb9D-4eppA:undetectable | 4qb9D-4eppA:22.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QOI_B_ML1B303_1 (RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE[QUINONE]) |
1txz | HYPOTHETICAL 32.1KDA PROTEIN INADH3-RCA1 INTERGENICREGION (Saccharomycescerevisiae) | 5 / 11 | ILE A 189GLY A 79PHE A 106ILE A 143PHE A 102 | NoneAPR A 285 (-3.6A)NoneNoneNone | 1.01A | 4qoiA-1txzA:undetectable4qoiB-1txzA:undetectable | 4qoiA-1txzA:21.334qoiB-1txzA:21.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R38_B_RBFB201_2 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
1txz | HYPOTHETICAL 32.1KDA PROTEIN INADH3-RCA1 INTERGENICREGION (Saccharomycescerevisiae) | 4 / 8 | THR A 195LEU A 31LEU A 21PHE A 89 | APR A 285 (-3.6A)NoneNoneAPR A 285 ( 4.9A) | 0.98A | 4r38B-1txzA:undetectable | 4r38B-1txzA:17.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RMJ_A_NCAA402_0 (NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-2) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 4 / 7 | ILE A 59PHE A 62ASN A 112ASP A 114 | NoneAPR A1296 (-3.6A)NoneNone | 0.30A | 4rmjA-3zg6A:18.7 | 4rmjA-3zg6A:25.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RMJ_A_NCAA402_0 (NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-2) |
4iao | NAD-DEPENDENTHISTONE DEACETYLASESIR2 (Saccharomycescerevisiae) | 5 / 7 | ILE A 271PHE A 274ASN A 345ILE A 346ASP A 347 | NoneAPR A 602 (-3.5A)NoneNoneNone | 0.41A | 4rmjA-4iaoA:31.5 | 4rmjA-4iaoA:25.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RS0_A_IBPA706_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 9 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.85A | 4rs0A-5dusA:undetectable | 4rs0A-5dusA:15.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XE3_A_CL6A502_1 (CYTOCHROME P-450) |
2hjr | MALATE DEHYDROGENASE (Cryptosporidiumparvum) | 4 / 5 | LEU A 58ALA A 22THR A 89ILE A 87 | NoneNoneAPR A3001 (-4.9A)None | 0.98A | 4xe3A-2hjrA:undetectable | 4xe3A-2hjrA:21.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XE3_B_CL6B502_1 (CYTOCHROME P-450) |
2hjr | MALATE DEHYDROGENASE (Cryptosporidiumparvum) | 4 / 5 | LEU A 58ALA A 22THR A 89ILE A 87 | NoneNoneAPR A3001 (-4.9A)None | 0.87A | 4xe3B-2hjrA:undetectable | 4xe3B-2hjrA:21.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YJI_A_TYLA502_1 (ARYL ACYLAMIDASE) |
3ewr | NON-STRUCTURALPROTEIN 3 (Humancoronavirus229E) | 4 / 7 | GLY A 43GLY A 44ALA A 47ILE A 126 | APR A 169 ( 4.5A)APR A 169 (-3.2A)APR A 169 (-3.4A)APR A 169 (-3.5A) | 0.45A | 4yjiA-3ewrA:undetectable | 4yjiA-3ewrA:14.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AXD_A_RBVA502_1 (ADENOSYLHOMOCYSTEINASE) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | HIS A 263ASP A 196THR A 144LEU A 259GLY A 204 | ZN A 387 ( 3.3A) ZN A 387 (-2.6A)APR A 389 (-4.0A)FE2 A 388 ( 4.1A)None | 1.35A | 5axdA-1rrmA:2.8 | 5axdA-1rrmA:23.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AXD_C_RBVC502_1 (ADENOSYLHOMOCYSTEINASE) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | HIS A 263ASP A 196THR A 144LEU A 259GLY A 204 | ZN A 387 ( 3.3A) ZN A 387 (-2.6A)APR A 389 (-4.0A)FE2 A 388 ( 4.1A)None | 1.35A | 5axdC-1rrmA:4.0 | 5axdC-1rrmA:23.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DPD_A_SAMA601_0 (PROTEIN LYSINEMETHYLTRANSFERASE 1) |
2hjr | MALATE DEHYDROGENASE (Cryptosporidiumparvum) | 5 / 12 | SER A 113SER A 145ILE A 147VAL A 86VAL A 152 | APR A3001 ( 4.8A)NoneNoneNoneNone | 0.98A | 5dpdA-2hjrA:5.1 | 5dpdA-2hjrA:20.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JVZ_A_FLPA601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.91A | 5jvzA-5dusA:undetectable | 5jvzA-5dusA:15.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JVZ_B_FLPB601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.92A | 5jvzB-5dusA:undetectable | 5jvzB-5dusA:15.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JW1_A_CELA602_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5dus | ORF1A (MiddleEastrespiratorysyndrome-relatedcoronavirus) | 5 / 12 | VAL A 158LEU A 162GLY A 128ALA A 127LEU A 124 | NoneNoneAPR A 201 (-3.3A)APR A 201 (-3.9A)None | 0.91A | 5jw1A-5dusA:undetectable | 5jw1A-5dusA:15.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KBW_A_RBFA201_1 (RIBOFLAVINTRANSPORTER RIBU) |
3gz8 | MUTT/NUDIX FAMILYPROTEIN (Shewanellaoneidensis) | 5 / 12 | GLU A 75LEU A 70GLY A 54LEU A 26ALA A 108 | NoneNoneAPR A 302 ( 4.1A)NoneNone | 1.25A | 5kbwA-3gz8A:undetectable | 5kbwA-3gz8A:23.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M66_A_ADNA502_1 (ADENOSYLHOMOCYSTEINASE) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | HIS A 263ASP A 196THR A 144LEU A 259GLY A 204 | ZN A 387 ( 3.3A) ZN A 387 (-2.6A)APR A 389 (-4.0A)FE2 A 388 ( 4.1A)None | 1.33A | 5m66A-1rrmA:2.6 | 5m66A-1rrmA:22.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M66_C_ADNC502_1 (ADENOSYLHOMOCYSTEINASE) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | HIS A 263ASP A 196THR A 144LEU A 259GLY A 204 | ZN A 387 ( 3.3A) ZN A 387 (-2.6A)APR A 389 (-4.0A)FE2 A 388 ( 4.1A)None | 1.35A | 5m66C-1rrmA:4.2 | 5m66C-1rrmA:22.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M66_C_ADNC502_1 (ADENOSYLHOMOCYSTEINASE) |
2qjo | BIFUNCTIONAL NMNADENYLYLTRANSFERASE/NUDIX HYDROLASE (Synechocystissp.PCC6803) | 5 / 12 | HIS A 328GLN A 330ASP A 205THR A 203PHE A 272 | APR A 501 (-4.0A)NoneAPR A 501 (-2.8A)APR A 501 (-3.6A)None | 1.35A | 5m66C-2qjoA:2.2 | 5m66C-2qjoA:21.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MWY_A_YNUA1101_1 (MINERALOCORTICOIDRECEPTOR) |
4epp | POLY(ADP-RIBOSE)GLYCOHYDROLASE (Tetrahymenathermophila) | 4 / 6 | PHE A 352CYH A 396THR A 222PHE A 230 | NoneAPR A 501 (-4.2A)NoneNone | 1.42A | 5mwyA-4eppA:undetectable | 5mwyA-4eppA:19.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OY0_1_PQN1842_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1PHOTOSYSTEM IREACTION CENTERSUBUNIT IX) |
5mqx | NON-STRUCTURALPROTEIN3 (Venezuelanequineencephalitisvirus) | 5 / 10 | ALA A 86LEU A 85GLY A 81ILE A 11LEU A 37 | NoneNoneNoneAPR A 201 (-3.3A)None | 1.25A | 5oy01-5mqxA:undetectable5oy07-5mqxA:undetectable | 5oy01-5mqxA:18.095oy07-5mqxA:16.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UTU_F_ADNF503_1 (ADENOSYLHOMOCYSTEINASE) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | HIS A 263ASP A 196THR A 144LEU A 259GLY A 204 | ZN A 387 ( 3.3A) ZN A 387 (-2.6A)APR A 389 (-4.0A)FE2 A 388 ( 4.1A)None | 1.35A | 5utuF-1rrmA:2.4 | 5utuF-1rrmA:22.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UUN_A_ACTA305_0 (GLUTATHIONES-TRANSFERASE-LIKEPROTEIN) |
1wvg | CDP-GLUCOSE4,6-DEHYDRATASE (Salmonellaenterica) | 3 / 3 | THR A 133MET A 89HIS A 88 | NoneAPR A 400 (-4.9A)None | 0.80A | 5uunA-1wvgA:undetectable | 5uunA-1wvgA:19.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VCG_A_08YA602_2 (CYTOCHROME P450 3A4) |
1wvg | CDP-GLUCOSE4,6-DEHYDRATASE (Salmonellaenterica) | 3 / 3 | ARG A 208ARG A 232ARG A 96 | APR A 400 ( 2.6A)CXY A 401 (-3.5A)None | 0.96A | 5vcgA-1wvgA:undetectable | 5vcgA-1wvgA:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VW9_A_NCAA403_0 (FERREDOXIN--NADPREDUCTASE) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 4 / 8 | THR A 193GLY A 194ALA A 197SER A 232 | APR A 389 (-4.5A)NoneNoneNone | 0.69A | 5vw9A-1rrmA:2.6 | 5vw9A-1rrmA:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y9Y_A_ACTA412_0 (UNCHARACTERIZEDPROTEIN KDOO) |
3gz8 | MUTT/NUDIX FAMILYPROTEIN (Shewanellaoneidensis) | 3 / 3 | ARG A 41PHE A 56ARG A 98 | APR A 302 (-3.1A)APR A 302 (-3.5A)APR A 302 (-2.9A) | 0.90A | 5y9yA-3gz8A:undetectable | 5y9yA-3gz8A:20.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YBB_B_SAMB601_1 (TYPE IRESTRICTION-MODIFICATION SYSTEMMETHYLTRANSFERASESUBUNIT) |
5cb5 | O-ACETYL-ADP-RIBOSEDEACETYLASE (Escherichiacoli) | 4 / 7 | ALA R 37GLY R 33GLY R 31THR R 13 | APR R 201 ( 3.8A)APR R 201 (-3.4A)APR R 201 (-3.6A)None | 0.79A | 5ybbB-5cb5R:undetectable | 5ybbB-5cb5R:14.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DEB_B_MTXB303_1 (BIFUNCTIONAL PROTEINFOLD) |
1txz | HYPOTHETICAL 32.1KDA PROTEIN INADH3-RCA1 INTERGENICREGION (Saccharomycescerevisiae) | 4 / 5 | TYR A 96GLN A 55GLY A 187ILE A 140 | NoneAPR A 285 (-3.5A)NoneNone | 1.08A | 6debB-1txzA:undetectable | 6debB-1txzA:14.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ECX_A_SAMA1301_1 (STIE PROTEIN) |
3zg6 | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-6 (Homosapiens) | 4 / 5 | THR A 242ARG A 251THR A 55ASP A 114 | NoneNoneAPR A1296 ( 3.1A)None | 1.33A | 6ecxA-3zg6A:2.9 | 6ecxA-3zg6A:24.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6F3N_B_ADNB505_1 (-) |
1rrm | LACTALDEHYDEREDUCTASE (Escherichiacoli) | 5 / 12 | HIS A 263ASP A 196THR A 144LEU A 259GLY A 204 | ZN A 387 ( 3.3A) ZN A 387 (-2.6A)APR A 389 (-4.0A)FE2 A 388 ( 4.1A)None | 1.40A | 6f3nB-1rrmA:4.3 | 6f3nB-1rrmA:23.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FGD_A_ACTA806_0 (GEPHYRIN) |
1wvg | CDP-GLUCOSE4,6-DEHYDRATASE (Salmonellaenterica) | 4 / 4 | MET A 89GLY A 18HIS A 19GLY A 24 | APR A 400 (-4.9A)APR A 400 (-3.2A)NoneNone | 1.23A | 6fgdA-1wvgA:1.6 | 6fgdA-1wvgA:21.43 |